Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 15, Number 11—November 2009

Research

Epidemic of Plasmodium falciparum Malaria Involving Substandard Antimalarial Drugs, Pakistan, 2003

Toby LeslieComments to Author , Harpakash Kaur, Nasir Mohammed, Kate Kolaczinski, Rosalynn L. Ord, and Mark Rowland
Author affiliations: London School of Hygiene and Tropical Medicine, London, UK (T. Leslie, H. Kaur, K. Kolaczinski, R.L. Ord, M. Rowland); HealthNet TPO, Kabul, Afghanistan (T. Leslie, N. Mohammed)

Main Article

Table 3

Frequency of treatment failure for infection with Plasmodium falciparum or P. vivax, by group, sex, and age, Pakistan, October 2003*

Characteristic Failure rate (%) Crude OR (95% CI) Adjusted OR (95% CI)
Group
Comparison group 4/40 (10.0) 1 1
Ashgaroo
43/151 (28.5)
3.6 (1.2–10.7)
3.2 (1.0–10.1)
Sex
M 27/90 (30.0) 1 1
F
20/99 (20.2)†
0.6 (0.3–1.2)
0.5 (0.3–1.2)
Age group, y
0–5 16/40 (40.0) 1 1
6–10 21/72 (29.2) 0.6 (0.3–1.4) 0.6 (0.3–1.1)
11–20 4/33 (12.2) 0.2 (0.1–0.7) 0.3 (0.1–1.0)
>20 6/46 (13.0) 0.2 (0.1–0.6) 0.3 (0.1–0.8)

*OR, odds ratio; CI, confidence interval.
†Results exclude losses to follow-up.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO